2Nelle M, Raio L, Pavlovic M, et al. Prenatal diagnosis and treatment planning of congenital heart defects - possibilities and limits. World J Pediatr,20119,5(1 ): 18-22.
3Whitlock RP,Sun JC,Fremes SE. Antithrombotic and thrombolytic therapy for valvular disease:Antithrombotic Therapy and Prevention of Thrombosis,9th ed:American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J].Chest,2012,(02):576-600.
4Akins CW,Miller DC,Turina MI. Guidelines for reporting mortality and morbidity after cardiac valve interventions[J].Journal of Thoracic and Cardiovascular Surgery,2008,(04):732-738.
5Kim YD,Cha M J,Kim J. Increases in cerebral atherosclerosis according to CHADS2 scores in patients with stroke with nonvalvular atrial fibrillation[J].Stroke,2011,(04):930-934.
6Grunkemeier GL,Fumary AP. Data variability and validity:the elephant in the room[J].Journal of Thoracic and Cardiovascular Surgery,2010,(02):273-275.
7Jamieson WR,Edwards FH,Schwartz M. Risk stratification for cardiac valve replacement.National Cardiac Surgery Database.Database Committee of the Society of Thoracic Surgeons[J].Annals of Thoracic Surgery,1999,(04):943-951.
8Gogbashian A,Sedrakyan A,Treasure T. EuroSCORE:a system-atic review of international performance[J].European Journal of Cardio-Thoracic Surgery,2004,(05):695-700.doi:10.1016/j.ejcts.2004.02.022.
9Edwards FH,Grover FL,Shroyer AL. The Society of Thoracic Surgeons National Cardiac Surgery database:current risk assessment[J].Annals of Thoracic Surgery,1997,(03):903-908.
10Nashef S,Roques F,Michel P. European System for Cardiac Operative Risk Evaluation (EuroSCORE)[J].European Journal of Cardio-Thoracic Surgery,1999,(01):9-13.
